Fascinatingly, CHCHD10 mutations were identified in these independent cohorts, firmly establishing a pathophysiological link with FTD‐ALS clinical spectrum (Chaussenot et al, 2014; Johnson et al, 2014; Müller et al, 2014; Chiò et al, 2015; Kurzwelly et al, 2015; Ronchi et al, 2015; Zhang et al, 2015). This evidence concerns the gene CHCHD10 and amyotrophic lateral sclerosis.